Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Harvard Business School
Baxter
Colorcon
Express Scripts
Merck
Mallinckrodt

Last Updated: August 13, 2022

Investigational Drug Information for Omecamtiv Mecarbil


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the development status for investigational drug Omecamtiv Mecarbil?

Omecamtiv Mecarbil is an investigational drug.

There have been 12 clinical trials for Omecamtiv Mecarbil. The most recent clinical trial was a Phase 3 trial, which was initiated on January 6th 2017.

The most common disease conditions in clinical trials are Heart Failure, Ventricular Dysfunction, Left, and Systolic Murmurs. The leading clinical trial sponsors are Cytokinetics, Amgen, and Servier.

There are forty-five US patents protecting this investigational drug and four hundred and seventy international patents.

Recent Clinical Trials for Omecamtiv Mecarbil
TitleSponsorPhase
Omecamtiv Mecarbil Post-trial Access StudyAmgenPhase 3
Omecamtiv Mecarbil Post-trial Access StudyCytokineticsPhase 3
Study to Assess the Effect of Omecamtiv Mecarbil (OM) on QT/QTc Intervals in Healthy AdultsAmgenPhase 1

See all Omecamtiv Mecarbil clinical trials

Clinical Trial Summary for Omecamtiv Mecarbil

Top disease conditions for Omecamtiv Mecarbil
Top clinical trial sponsors for Omecamtiv Mecarbil

See all Omecamtiv Mecarbil clinical trials

US Patents for Omecamtiv Mecarbil

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Omecamtiv Mecarbil See Plans and Pricing Compounds, compositions and methods Cytokinetics, Incorporated (South San Francisco, CA) See Plans and Pricing
Omecamtiv Mecarbil See Plans and Pricing sGC stimulators Ironwood Pharmaceuticals, Inc. (Cambridge, MA) See Plans and Pricing
Omecamtiv Mecarbil See Plans and Pricing Controlled release dosage form TRIASTEK, INC. (Nanjing, CN) See Plans and Pricing
Omecamtiv Mecarbil See Plans and Pricing sGC stimulators Ironwood Pharmaceuticals, Inc. (Cambridge, MA) See Plans and Pricing
Omecamtiv Mecarbil See Plans and Pricing Oral drug dosage forms having desired drug release profiles and uses thereof Triastek, Inc. (Nanjing, CN) See Plans and Pricing
Omecamtiv Mecarbil See Plans and Pricing Fused imidazole derivatives as IDO/TDO inhibitors SciFluor Life Sciences, Inc. (Cambridge, MA) See Plans and Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Omecamtiv Mecarbil

Drugname Country Document Number Estimated Expiration Related US Patent
Omecamtiv Mecarbil Argentina AR053405 2024-06-17 See Plans and Pricing
Omecamtiv Mecarbil Australia AU2005264988 2024-06-17 See Plans and Pricing
Omecamtiv Mecarbil Brazil BRPI0512193 2024-06-17 See Plans and Pricing
Omecamtiv Mecarbil Canada CA2570999 2024-06-17 See Plans and Pricing
Omecamtiv Mecarbil China CN101035525 2024-06-17 See Plans and Pricing
Omecamtiv Mecarbil Cyprus CY1115716 2024-06-17 See Plans and Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Baxter
Colorcon
Express Scripts
Merck
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.